Subscribe to My Feed




Tell a Friend




  • Polls

    How Is My Site? / ¿Cómo es mi sitio web?

    View Results

    Loading ... Loading ...
  • Recent Comments:

  • Important LAC Developments on Clinical Trials

    Monday, March 23rd, 2009

    Argentina and Brazil are creating national registries for clinical trials. Clinical trials are research studies that prospectively assign human participants or groups of humans to one or more health-related interventions (pharmaceuticals, vaccines, surgical procedures, radiological procedures, medical devices, etc.) to evaluate the effects on health outcomes, often undertaken with a view to seeking regulatory approval. […]

    Share

    A Water and Sanitation Atlas for Brazil

    Wednesday, December 24th, 2008

    Last month a branch of the Oswaldo Cruz Foundation (“Fiocruz“), the Institute of Communication and Scientific and Technological Information in Health (Instituto de Comunicação e Informação Científica e Tecnológica em Saúde – Icict), in partnership with the Health Ministry’s (MS) General Coordination for Environmental Health Surveillance (Coordenação Geral de Vigilância em Saúde Ambiental – CGVAM), […]

    Share

    Improving the Environment and Health of Manaus

    Friday, July 11th, 2008

    Synopsis in English: Researchers at the Amazonian branch of Brazil’s much respected health R&D institution, the Oswaldo Cruz Foundation (popularly known as “Fiocruz“), and the National School of Public Health (ENSP) overseen by Fiocruz, will study the major environmental and health problems of Manaus, the capital of Amazonas state (and some would say of the […]

    Share

    Brazil Develops Faster Hepatitis A Diagnostic

    Friday, May 25th, 2007

    Synopsis in English: If you are not Brazilian or involved in international public health, you may not recognize the name of the Oswaldo Cruz Foundation (Fundação Oswaldo Cruz), better known by its nickname Fiocruz. I could write a whole post (or several) just on Fiocruz and its importance, and perhaps someday I will. Suffice it […]

    Share